Ping Zhan

GSDMD is required for effector CD8+ T cell responses to lung cancer cells

Guangmin Xi, Jianwei Gao, Bing Wan et al. · International Immunopharmacology · 2019 · 189 citations

Cancer Immunosurveillance, Medicine, T-regulatory Cell +10

PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway

Ping Zhan, Bin Zhang, Guangmin Xi et al. · Molecular Cancer · 2017 · 144 citations · Full text

Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer

Zhou Li, Qiuli Xu, Litang Huang et al. · Cancer Letters · 2020 · 110 citations

Cancer Immunosurveillance, Medicine, Immunology +12

Antifungal Susceptibility and Mutations in the Squalene Epoxidase Gene in Dermatophytes of the Trichophyton mentagrophytes Species Complex

Xue Kong, Chao Tang, Ashutosh Singh et al. · Antimicrobial Agents and Chemotherapy · 2021 · 98 citations · Full text

Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis

Zimu Wang, Ping Zhan, Yanling Lv et al. · Translational Lung Cancer Research · 2019 · 87 citations · Full text